Famprya – a casualty of the inequity in Health Spending?

[Speaking in the Seanad during Statements on Availability of Certain Medication] The Minister is very familiar with the whole concept of health economics. I do not believe for one second that medicine can be practised in an economic vacuum. I understand that every decision made about a patient has an opportunity cost for another patient … Continue reading

The need for the MS drug Famprya to remain funded by the State

[Speaking in the Seanad during Order of Business] I would be grateful if the Deputy Leader could find out something for me. I was very distressed to find out from a patient, in correspondence I received this morning, that the drug fampyra, which has been shown to improve the ability of patients with multiple sclerosis … Continue reading